BridgeBio Pharma (BBIO) Share-based Compensation (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.03% |
| Dec 31, 2025 | -1.77% |
| Sep 30, 2025 | -5.56% |
| Jun 30, 2025 | 44.27% |
| Mar 31, 2025 | -14.09% |
| Dec 31, 2024 | 11.04% |
| Sep 30, 2024 | 26.48% |
| Jun 30, 2024 | -25.65% |
| Mar 31, 2024 | -22.08% |
| Dec 31, 2023 | 35.97% |
| Sep 30, 2023 | 0.20% |
| Jun 30, 2023 | 24.05% |
| Mar 31, 2023 | 7.84% |
| Dec 31, 2022 | 8.88% |
| Sep 30, 2022 | -34.08% |
| Jun 30, 2022 | 16.57% |
| Mar 31, 2022 | 7.85% |
| Dec 31, 2021 | 39.57% |
| Sep 30, 2021 | -49.65% |
| Jun 30, 2021 | -8.20% |
| Mar 31, 2021 | 187.30% |
| Dec 31, 2020 | -31.37% |
| Sep 30, 2020 | -3.77% |
| Jun 30, 2020 | 79.93% |
| Mar 31, 2020 | 2.15% |
| Dec 31, 2019 | 73.22% |
| Sep 30, 2019 | 72.04% |
| Jun 30, 2019 | 50.45% |
| Mar 31, 2019 | -28.30% |
| Dec 31, 2018 | 937.67% |
| Sep 30, 2018 | 200.00% |